selected publications
- Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions. 2024 GET IT
- Breast Cancer Macrophage Heterogeneity and Self-renewal are Determined by Spatial Localization. 2023 GET IT
- Integration of whole transcriptome spatial profiling with protein markers. Nature biotechnology. 2023 Academic Article GET IT
- Mouse Modeling Dissecting Macrophage-Breast Cancer Communication Uncovered Roles of PYK2 in Macrophage Recruitment and Breast Tumorigenesis. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2022 Academic Article GET IT
-
Imaging endogenous macrophage iron deposits reveals a metabolic biomarker of polarized tumor macrophage infiltration and response to CSF1R breast cancer immunotherapy.
Scientific reports.
2019
Academic Article
GET IT
Times cited: 25 -
Iron imaging reveals tumor and metastasis macrophage hemosiderin deposits in breast cancer.
PloS one.
2017
Academic Article
GET IT
Times cited: 29 -
Obesity alters the lung myeloid cell landscape to enhance breast cancer metastasis through IL5 and GM-CSF.
Nature cell biology.
2017
Academic Article
GET IT
Times cited: 202 -
Tumor Cell Invasion Can Be Blocked by Modulators of Collagen Fibril Alignment That Control Assembly of the Extracellular Matrix.
Cancer research.
2016
Academic Article
GET IT
Times cited: 62 -
EGF induces microRNAs that target suppressors of cell migration: miR-15b targets MTSS1 in breast cancer.
Science signaling.
2015
Academic Article
GET IT
Times cited: 51 -
Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progression.
EMBO molecular medicine.
2015
Academic Article
GET IT
Times cited: 34 -
Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer.
Science signaling.
2015
Academic Article
GET IT
Times cited: 36 -
Identification of novel DNA-damage tolerance genes reveals regulation of translesion DNA synthesis by nucleophosmin.
Nature communications.
2014
Academic Article
GET IT
Times cited: 47 -
Diurnal suppression of EGFR signalling by glucocorticoids and implications for tumour progression and treatment.
Nature communications.
2014
Academic Article
GET IT
Times cited: 59 -
Epidermal growth-factor-induced transcript isoform variation drives mammary cell migration.
PloS one.
2013
Academic Article
GET IT
Times cited: 16 -
Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR.
Proceedings of the National Academy of Sciences of the United States of America.
2013
Academic Article
GET IT
Times cited: 97 -
ERK-ERF-EGR1, a novel switch underlying acquisition of a motile phenotype.
Cell adhesion & migration.
2012
Article
GET IT
Times cited: 11 -
EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
2011
Academic Article
GET IT
Times cited: 81 -
Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression.
Oncogene.
2011
Academic Article
GET IT
Times cited: 82 -
Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions.
Oncogene.
2011
Academic Article
GET IT
Times cited: 32 -
A recombinant decoy comprising EGFR and ErbB-4 inhibits tumor growth and metastasis.
Oncogene.
2011
Academic Article
GET IT
Times cited: 30 -
Combining epitope-distinct antibodies to HER2: cooperative inhibitory effects on invasive growth.
Oncogene.
2010
Academic Article
GET IT
Times cited: 17 -
A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration.
Nature cell biology.
2007
Academic Article
GET IT
Times cited: 134